Amir Moradi MD, MBA
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris (NCT04240535) | Amir Moradi MD, MBA | 2020-01-01 |
Track Amir Moradi MD, MBA automatically
Every clearance here is in the API, with alerts when new ones post.